A decision aid for women at increased risk for ovarian cancer

被引:12
|
作者
Tiller, K [1 ]
Meiser, B
Reeson, E
Tucker, M
Andrews, L
Gaff, C
Kirk, J
Phillips, KA
Friedlander, M
机构
[1] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia
[2] Royal N Shore Hosp, Dept Psychol Med, Sydney, NSW, Australia
[3] Royal N Shore Hosp, NSW Genet Educ Program, Sydney, NSW, Australia
[4] Genet Hlth Serv, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Familial Canc Ctr, Melbourne, Vic, Australia
[6] Westmead Hosp, Familial Canc Serv, Sydney, NSW, Australia
[7] Peter MacCallum Canc Inst, Div Haematol & Med Oncol, Melbourne, Vic 3000, Australia
[8] Peter MacCallum Canc Inst, Familial Canc Ctr, Melbourne, Vic 3000, Australia
[9] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia
关键词
decision aids; hereditary ovarian cancer; risk management options;
D O I
10.1046/j.1525-1438.2003.13018.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper reviews changes that have occurred within and without the medical profession that have fostered an increasing demand for decision aids as adjuncts to practitioners' counseling to prepare patients for decision making. In the absence of data on the efficacy of ovarian cancer screening and prophylactic strategies, decisions about optimal care are difficult for both women and their doctors. Because surveillance and preventive options are an area of great uncertainty, a decision aid has been developed specifically aimed at facilitating decisions involving ovarian cancer risk management options. This was achieved by reviewing and integrating the available literature on models of medical decision making, patient preferences for information and involvement in decision making, the utility of decision aids, and management options for ovarian cancer risk. Findings indicate that patients wish to be informed participants in the decision-making process and that decision aids are an acceptable and effective method of providing quality information in a format that facilitates an inclusive model of shared decision making. A decision aid designed for women at increased risk of ovarian cancer that facilitates informed decision making may be a valuable addition to patient support. A randomized controlled trial of this type of educational material will provide timely and much needed evidence on its acceptability and efficacy.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [1] A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer
    Tiller, K.
    Meiser, B.
    Gaff, C.
    Kirk, J.
    Dudding, T.
    Phillips, K. -A.
    Friedlander, M.
    Tucker, K.
    [J]. MEDICAL DECISION MAKING, 2006, 26 (04) : 360 - 372
  • [2] A randomised trial of a decision aid for women at risk for ovarian cancer
    Tiller, K
    Meiser, B
    Tucker, K
    Andrews, L
    Gaff, C
    Kirk, J
    Phillips, KA
    Duding, T
    Friedlander, M
    [J]. PSYCHO-ONCOLOGY, 2003, 12 (04) : S107 - S107
  • [3] Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer
    Meiser, Bettina
    Price, Melanie A.
    Butow, Phyllis N.
    Rahman, Belinda
    Tucker, Kathy
    Cheah, Benjamin
    Bickerstaffe, Adrian
    Hopper, John
    Phillips, Kelly-Anne
    [J]. FAMILIAL CANCER, 2014, 13 (02) : 153 - 162
  • [4] Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer
    Bettina Meiser
    Melanie A. Price
    Phyllis N. Butow
    Belinda Rahman
    Kathy Tucker
    Benjamin Cheah
    Adrian Bickerstaffe
    John Hopper
    Kelly-Anne Phillips
    [J]. Familial Cancer, 2014, 13 : 153 - 162
  • [5] A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
    Claire E. Wakefield
    Bettina Meiser
    Judi Homewood
    Michelle Peate
    Alan Taylor
    Elizabeth Lobb
    Judy Kirk
    Mary-Anne Young
    Rachel Williams
    Tracy Dudding
    Kathy Tucker
    [J]. Breast Cancer Research and Treatment, 2008, 107 : 289 - 301
  • [6] A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
    Wakefield, Claire E.
    Meiser, Bettina
    Homewood, Judi
    Peate, Michelle
    Taylor, Alan
    Lobb, Elizabeth
    Kirk, Judy
    Young, Mary-Anne
    Williams, Rachel
    Dudding, Tracy
    Tucker, Kathy
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (02) : 289 - 301
  • [7] Increased risk for ovarian cancer and borderline ovarian tumors in subfertile women with endometriosis
    Burger, C.
    Buis, C.
    Mooij, T.
    van Leeuwen, F.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S10 - S11
  • [8] Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis
    Buis, C. C. M.
    van Leeuwen, F. E.
    Mooij, T. M.
    Burger, C. W.
    [J]. HUMAN REPRODUCTION, 2013, 28 (12) : 3358 - 3369
  • [9] Utility of symptom index in women at increased risk for ovarian cancer
    Singh, D.
    Lowe, K.
    Colllins, C.
    Cohen, L.
    Dungan, J.
    Shulman, L.
    Andersen, M.
    Goff, B.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S61 - S61
  • [10] Model of care for women at increased risk of breast and ovarian cancer
    De Bock, Geertruida H.
    Hesselink, Jan Willem
    Roorda, Carriene
    De Vries, Jaap
    Hollema, Harry
    Jaspers, Jan P. C.
    Kok, Theo
    Werker, Paul M. N.
    Oosterwijk, Jan C.
    Mounts, Marian J. E.
    [J]. MATURITAS, 2012, 71 (01) : 3 - 5